FdaApplication

NDA 219921

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAVYXA HOLDINGS LLC
application_typeNDA
approval_date2025-08-08

Products (3)

ProductActive ingredientStrengthDosage form
KYXATACARBOPLATIN500MG/50ML (10MG/ML)SOLUTION;INTRAVENOUS
KYXATACARBOPLATIN80MG/8ML (10MG/ML)SOLUTION;INTRAVENOUS
KYXATACARBOPLATIN20MG/2ML (10MG/ML)SOLUTION;INTRAVENOUS

3 products